Making Regulatory Decisions Not Part Of NAD’s Job Description
This article was originally published in The Tan Sheet
Executive Summary
The National Advertising Division says it is not taking on a regulatory role to determine whether a product should be considered a drug or a supplement while it continues recommending whether advertising for OTC drugs or supplements is false or misleading
You may also be interested in...
FTC Supports NAD, But Does Not Mirror The CBBB Division’s Transparency
The federal and private entities monitoring dietary supplement health claims are not created equal, says attorney Anthony L. Young
FTC Supports NAD, But Does Not Mirror The CBBB Division’s Transparency
The federal and private entities monitoring dietary supplement health claims are not created equal, says attorney Anthony L. Young
FTC Supports NAD, But Does Not Mirror The CBBB Division’s Transparency
The federal and private entities monitoring dietary supplement health claims are not created equal, says attorney Anthony L. Young